221 related articles for article (PubMed ID: 33011973)
1. Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models.
Karimnia V; Rizvi I; Slack FJ; Celli JP
Photochem Photobiol; 2021 Mar; 97(2):416-426. PubMed ID: 33011973
[TBL] [Abstract][Full Text] [Related]
2. Photoimmunotherapy Retains Its Anti-Tumor Efficacy with Increasing Stromal Content in Heterotypic Pancreatic Cancer Spheroids.
Saad MA; Zhung W; Stanley ME; Formica S; Grimaldo-Garcia S; Obaid G; Hasan T
Mol Pharm; 2022 Jul; 19(7):2549-2563. PubMed ID: 35583476
[TBL] [Abstract][Full Text] [Related]
3. ECM Composition and Rheology Regulate Growth, Motility, and Response to Photodynamic Therapy in 3D Models of Pancreatic Ductal Adenocarcinoma.
Cramer GM; Jones DP; El-Hamidi H; Celli JP
Mol Cancer Res; 2017 Jan; 15(1):15-25. PubMed ID: 27671335
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor Models.
Karimnia V; Stanley ME; Fitzgerald CT; Rizvi I; Slack FJ; Celli JP
Photochem Photobiol; 2023 Jan; 99(1):120-131. PubMed ID: 35699307
[TBL] [Abstract][Full Text] [Related]
5. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
6. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
[No Abstract] [Full Text] [Related]
7. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
8. Impacting Pancreatic Cancer Therapy in Heterotypic
Obaid G; Bano S; Mallidi S; Broekgaarden M; Kuriakose J; Silber Z; Bulin AL; Wang Y; Mai Z; Jin W; Simeone D; Hasan T
Nano Lett; 2019 Nov; 19(11):7573-7587. PubMed ID: 31518145
[TBL] [Abstract][Full Text] [Related]
9. Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties.
Rubiano A; Delitto D; Han S; Gerber M; Galitz C; Trevino J; Thomas RM; Hughes SJ; Simmons CS
Acta Biomater; 2018 Feb; 67():331-340. PubMed ID: 29191507
[TBL] [Abstract][Full Text] [Related]
10. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
Hwang HJ; Oh MS; Lee DW; Kuh HJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
[TBL] [Abstract][Full Text] [Related]
11. Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer.
Neumann CCM; von Hörschelmann E; Reutzel-Selke A; Seidel E; Sauer IM; Pratschke J; Bahra M; Schmuck RB
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):461-472. PubMed ID: 30243879
[TBL] [Abstract][Full Text] [Related]
12. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY
Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812
[TBL] [Abstract][Full Text] [Related]
13. A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.
Drifka CR; Eliceiri KW; Weber SM; Kao WJ
Lab Chip; 2013 Oct; 13(19):3965-75. PubMed ID: 23959166
[TBL] [Abstract][Full Text] [Related]
14. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.
Ma Y; Hwang RF; Logsdon CD; Ullrich SE
Cancer Res; 2013 Jul; 73(13):3927-37. PubMed ID: 23633481
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J
Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125
[TBL] [Abstract][Full Text] [Related]
17. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
18. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
Wong CW; Han HW; Tien YW; Hsu SH
Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment.
Lu J; Roy B; Anderson M; Leggett CL; Levy MJ; Pogue B; Hasan T; Wang KK
J Biomed Opt; 2019 Nov; 24(11):1-11. PubMed ID: 31741351
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
